Hiroshi Mitoma Selected Research

Cerebellar Ataxia (Dysmetria)

4/2022	Consensus Paper: Ataxic Gait.
2/2022	The Clinical Concept of LTDpathy: Is Dysregulated LTD Responsible for Prodromal Cerebellar Symptoms?
1/2022	Advances in the Pathogenesis of Auto-antibody-Induced Cerebellar Synaptopathies.
5/2021	[Immune-Mediated Cerebellar Ataxias].
1/2021	Cerebellar long-term depression and auto-immune target of auto-antibodies: the concept of LTDpathies.
1/2021	Mechanisms of Ethanol-Induced Cerebellar Ataxia: Underpinnings of Neuronal Death in the Cerebellum.
1/2021	Immune-Mediated Cerebellar Ataxias: Clinical Diagnosis and Treatment Based on Immunological and Physiological Mechanisms.
7/2020	Fundamental Mechanisms of Autoantibody-Induced Impairments on Ion Channels and Synapses in Immune-Mediated Cerebellar Ataxias.
6/2019	Task Force Paper On Cerebellar Transplantation: Are We Ready to Treat Cerebellar Disorders with Cell Therapy?
4/2019	Anti-GAD Antibodies and the Cerebellum: Where Do We Stand?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Mitoma Research Topics

Disease

30	Cerebellar Ataxia (Dysmetria) 04/2022 - 04/2003
15	Ataxia (Dyssynergia) 05/2021 - 01/2009
5	Parkinson Disease (Parkinson's Disease) 07/2021 - 01/2017
5	Paraneoplastic Cerebellar Degeneration 05/2021 - 01/2015
5	Neoplasms (Cancer) 01/2019 - 10/2014
3	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2021 - 01/2015
3	Cerebellar Diseases (Cerebellar Syndrome) 06/2019 - 01/2018
3	Atrophy 01/2016 - 01/2009
3	Multiple System Atrophy 01/2016 - 01/2009
2	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2021 - 01/2019
2	Disease Progression 12/2019 - 01/2017
2	Hashimoto's encephalitis 04/2016 - 01/2015
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2016 - 10/2014
2	Stiff-Person Syndrome (Stiff Man Syndrome) 01/2015 - 05/2013
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2015 - 02/2007
1	Communicable Diseases (Infectious Diseases) 02/2022
1	Alcoholism (Alcohol Abuse) 01/2021
1	Fetal Alcohol Spectrum Disorders 01/2021
1	Thiamine Deficiency 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 08/2020
1	Infections 08/2020
1	Leukocytosis (Pleocytosis) 08/2020
1	Cytokine Release Syndrome 08/2020
1	Movement Disorders (Movement Disorder) 08/2019
1	Brain Diseases (Brain Disorder) 12/2018
1	Wounds and Injuries (Trauma) 08/2018
1	Multiple Sclerosis 08/2018
1	Stroke (Strokes) 08/2018
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2016
1	Miller Fisher Syndrome (Fisher Syndrome) 04/2016
1	Nervous System Diseases (Neurological Disorders) 01/2015
1	Medically Unexplained Symptoms 05/2009
1	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 01/2009

Drug/Important Bio-Agent (IBA)

10	AutoantibodiesIBA 07/2020 - 04/2003
9	AntibodiesIBA 02/2022 - 01/2009
9	Glutens (Glutelin)IBA 05/2021 - 01/2009
8	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2017 - 04/2003
5	GliadinIBA 01/2016 - 01/2009
4	Proteins (Proteins, Gene)FDA Link 02/2022 - 07/2020
3	EpitopesIBA 01/2017 - 01/2015
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2015 - 01/2009
2	Biomarkers (Surrogate Marker)IBA 04/2022 - 08/2020
2	Glutamate Receptors (Glutamate Receptor)IBA 02/2022 - 01/2021
2	metabotropic glutamate receptor type 1IBA 02/2022 - 01/2021
2	Carboxy-LyasesIBA 05/2021 - 01/2019
2	Ion Channels (Ion Channel)IBA 01/2021 - 07/2020
2	Immunosuppressive Agents (Immunosuppressants)IBA 08/2020 - 01/2015
2	Phenytoin (Dilantin)FDA LinkGeneric 01/2016 - 10/2014
1	Pharmaceutical PreparationsIBA 07/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2021
1	Oligoclonal BandsIBA 08/2020
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 07/2020
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 08/2019
1	istradefyllineIBA 08/2019
1	AntigensIBA 01/2019
1	AntioxidantsIBA 01/2019
1	AminopyridinesIBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 12/2018
1	Selegiline (E250)FDA LinkGeneric 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2015
1	Protein Isoforms (Isoforms)IBA 01/2015
1	Peptides (Polypeptides)IBA 10/2014
1	gamma-Aminobutyric Acid (GABA)IBA 05/2013
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 05/2009
1	Immunoglobulin A (IgA)IBA 01/2009
1	SS-A antibodiesIBA 01/2009
1	Immunoglobulin G (IgG)IBA 02/2007

Therapy/Procedure

10	Therapeutics 01/2021 - 01/2009
5	Immunotherapy 01/2017 - 01/2009
3	Wearable Electronic Devices 04/2020 - 01/2017
2	Gluten-Free Diet 01/2019 - 10/2014
1	Cell- and Tissue-Based Therapy (Cell Therapy) 06/2019
1	Transplantation 06/2019
1	Activities of Daily Living (ADL) 09/2016
1	Oral Administration 10/2014